Isogenic human stem cell models reveal mutation-dependent protective mechanisms of APOE3 Christchurch

Classified as probably not a substantial claim.

The APOE gene plays a central role in modulating Alzheimer's disease risk through lipid transport, synaptic function, and amyloid-beta metabolism in the brain.

“Among these, the APOE gene plays a central role in modulating disease risk, primarily through its involvement in lipid transport, synaptic function, and amyloid-beta metabolism in the brain (Martens et al., 2022; Raulin et al., 2022).”

• cites Martens et al., 2022 sourceSupported
• cites Raulin et al., 2022 sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

A small subset of Alzheimer's disease cases is caused by autosomal-dominant AD mutations in PSEN1, PSEN2, and APP, leading to early-onset AD with amyloid plaques and neurofibrillary tangles.

“While most cases are sporadic (SAD), a small subset is caused by autosomal-dominant AD (ADAD) mutations in presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein (APP), leading to early-onset AD with hallmark amyloid plaques and neurofibrillary tangles (Bateman et al., 2011; Bird, 2008; Selkoe and Hardy, 2016).”

• cites Bateman et al., 2011 sourceSupported
• cites Bird, 2008 sourceNot checked — no full text of the source
• cites Selkoe and Hardy, 2016 sourceSupported

Classified as probably not a substantial claim. May combine two claims.

In the central nervous system, neurons are the primary source of extracellular Aβ, generated through amyloidogenic processing of APP, while non-neuronal cells, particularly astrocytes, play important roles in Aβ uptake and clearance.

“In the central nervous system, neurons are the primary source of extracellular Aβ, which is generated through amyloidogenic processing of amyloid precursor protein (APP), while non-neuronal cells, particularly astrocytes, play important roles in Aβ uptake and clearance from the extracellular space (Liu et al., 2013).”

• cites Liu et al., 2013 sourcePartly supported

  The Introduction states that Aβ is generated by cleavage of APP. The “Aβ metabolism and aggregation” section discusses Aβ clearance, possible cellular uptake of ApoE–Aβ complexes, and degradation by microglia. It does not identify neurons as the primary source of extracellular Aβ or specifically establish astrocytes as important cells for its uptake and clearance; its statement that astrocytes primarily produce ApoE concerns a different protein. The indexed passages provide section labels but no page numbers. (LLM, conf=0.86)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

APOE4 increases Alzheimer's disease susceptibility and APOE2 offers protection.

“The three primary APOE isoforms (APOE2, APOE3, and APOE4) have distinct effects on AD onset and age-related progression, with APOE4 increasing susceptibility and APOE2 offering protection (Corder et al., 1993; Saunders et al., 1993; Wolf et al., 2013).”

• cites Corder et al., 1993 sourceNot checked — no full text of the source
• cites Saunders et al., 1993 sourcePartly supported

  The paper’s Discussion reports an association between APOE ε4 and late-onset familial and sporadic Alzheimer’s disease, supporting the susceptibility portion of the claim. Our copy identifies ε2 as an allele but does not say it offers protection; it also does not establish distinct effects of all three isoforms on age-related progression. (LLM, conf=0.90)

  Experimental — accuracy not yet measured
• cites Wolf et al., 2013 sourceSupported

Classified as probably not a substantial claim. May combine two claims.

APOE regulates extracellular Aβ metabolism independently of Aβ synthesis, and APOE isoforms differentially influence the clearance of soluble Aβ from the brain.

“Indeed, APOE has been shown to regulate extracellular Aβ metabolism independently of Aβ synthesis, and APOE isoforms differentially influence the clearance of soluble Aβ from the brain (Castellano et al., 2011; DeMattos et al., 2004).”

• cites Castellano et al., 2011 sourceSupported
• cites DeMattos et al., 2004 sourceNot checked — no full text of the source

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

Increased Aβ production can contribute substantially to extracellular Aβ accumulation and the amyloid cascade underlying Alzheimer's disease pathology, but impaired turnover and clearance can also promote Aβ accumulation.

“Increased Aβ production can contribute substantially to extracellular Aβ accumulation and the amyloid cascade underlying Alzheimer’s disease pathology (Chow et al., 2010; Zhang et al., 2011) but impaired turnover and clearance can also promote Aβ accumulation.”

• cites Chow et al., 2010 sourceSupported
• cites Zhang et al., 2011 sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

The PS1E280A individual would likely have exhibited a substantially greater amyloid burden in the absence of the protective APOE3ch genotype.

“The original case report further suggested that the PS1E280A individual would likely have exhibited a substantially greater amyloid burden in the absence of the protective APOE3ch genotype (Arboleda-Velasquez et al., 2019).”

• cites Arboleda-Velasquez et al., 2019 sourcePartly supported

  The passage on Aβ42 aggregation (Abstract) suggests that the subject may have had greater Aβ plaque deposition without APOE3ch/3ch, had she survived to her seventies. The citing sentence strengthens “may have had even greater” to “would likely have exhibited a substantially greater” burden and omits the survival condition; the source does not establish that likelihood or magnitude. (LLM, conf=0.84)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

Off-target analysis was conducted for PS1E280A and APOE3ch, identifying the top 3 off-target sites.

“Off-target analysis for PS1E280A and APOE3ch was conducted using protocols outlined in previous publications (Frisch et al., 2023), identifying the top 3 off-target sites.”

• cites Frisch et al., 2023 sourceSupported

May combine two claims.

Compared with APOE3, APOE4 increases and APOE2 decreases levels of secreted Aβ in isogenic hiPSCs.

“Similarly, our work with isogenic hiPSCs has shown that, compared with APOE3, APOE4 increases and APOE2 decreases levels of secreted Aβ (Brookhouser et al., 2021; Zhao et al., 2020).”

• cites Brookhouser et al., 2021 sourcePartly supported

  The Results section (‘APOE2 modulates AD-related phenotypes in hiPSC-derived neural cultures’; page unavailable) reports that APOE2 reduced secreted Aβ40 and Aβ42 relative to APOE3 in isogenic cultures with familial AD mutations. It also reports no reduction in non-demented control cultures. This paper does not report an APOE4-versus-APOE3 increase in secreted Aβ from its isogenic hiPSC experiments, so it supports the APOE2 portion but not the full unqualified claim. (LLM, conf=0.86)

  Experimental — accuracy not yet measured
• cites Zhao et al., 2020 sourcePartly supported

  The Results section on isogenic conversion (Fig. 7; page unavailable) reports lower Aβ40 and Aβ42 in APOE3 cerebral organoids than in their APOE4 parental line, supporting the APOE4-versus-APOE3 direction. Those measurements were from organoid lysates, not secreted Aβ, and the paper does not report an APOE2 comparison. (LLM, conf=0.88)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

APOE3 genotype leads to higher total APOE levels compared to APOE4 genotype.

“Research in animal models (Bien-Ly et al., 2012) and hiPSC-based models (Wang et al., 2018) has indicated that the APOE3 genotype leads to higher total APOE levels compared to the APOE4 genotype.”

• cites Bien-Ly et al., 2012 sourceSupported
• cites Wang et al., 2018 sourcePartly supported

  The Results section on apoE production (page unavailable) reports that apoE4/4 hiPSC-derived neurons had less full-length intracellular and secreted apoE than apoE3/3 neurons. It also reports more apoE fragments in apoE4/4 neurons, so the comparison supports higher full-length apoE with APOE3 but does not establish higher total apoE across full-length protein and fragments. (LLM, conf=0.86)

  Experimental — accuracy not yet measured

Classified as probably not a substantial claim. May combine two claims.

Receptors such as LRP1 can regulate APP endocytosis and amyloidogenic processing while also mediating cellular uptake and clearance of extracellular Aβ.

“Receptors such as LRP1 can regulate APP endocytosis and amyloidogenic processing while also mediating cellular uptake and clearance of extracellular Aβ (Kanekiyo and Bu, 2014; Kanekiyo et al., 2013; Van Gool et al., 2019).”

• cites Kanekiyo and Bu, 2014 sourceSupported
• cites Kanekiyo et al., 2013 sourcePartly supported

  The Introduction and Discussion support LRP1-mediated neuronal uptake and clearance of Aβ. The Results report that deleting neuronal LRP1 did not significantly affect APP processing in the aged APP/PS1 mice studied, and the paper does not establish that LRP1 regulates APP endocytosis. Page numbers were not available in our copy. (LLM, conf=0.88)

  Experimental — accuracy not yet measured
• cites Van Gool et al., 2019 sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

APOE genotypes might influence GABAergic interneuron generation and survival.

“Previous studies with mouse (Andrews-Zwilling et al., 2010) and hiPSC-based (Wang et al., 2018) systems have shown that APOE genotypes might influence GABAergic interneuron generation and survival.”

• cites Andrews-Zwilling et al., 2010 sourcePartly supported

  The Results sections on age-dependent interneuron loss and Tau removal report fewer GABAergic interneurons in apoE4 mice and reduced survival in primary neuronal cultures. They support an effect on survival, but the paper does not establish an effect on GABAergic interneuron generation. (LLM, conf=0.88)

  Experimental — accuracy not yet measured
• cites Wang et al., 2018 sourcePartly supported

  The Results section reports greater degeneration and apoptotic death of APOE4/4-derived GABAergic neurons than APOE3/3-derived neurons, supporting an effect on survival. It also reports no early difference in GABA-positive neuron numbers and says the effect is not developmental, so this study does not support an effect on interneuron generation. (LLM, conf=0.88)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

Astrocytes are the primary source of APOE production in the brain, and disease-related phenotypes are influenced by interactions between astrocyte-secreted APOE and neurons.

“This is significant because astrocytes are the primary source of APOE production in the brain, and disease-related phenotypes are influenced by the interactions between astrocyte-secreted APOE and neurons (Huang, 2010; Huang and Mucke, 2012).”

• cites Huang, 2010 sourceNot checked — no full text of the source
• cites Huang and Mucke, 2012 sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

Karyotype analysis was conducted for each clonal line.

“Karyotype analysis was conducted for each clonal line by Cell Line Genetics, utilizing standard procedures for G-banding as we have previously described (Frisch et al., 2023).”

• cites Frisch et al., 2023 sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

Aberrant Wnt signaling has been implicated in Aβ production, tau phosphorylation, and synapse loss in multiple models.

“Aberrant Wnt signaling has been implicated in Aβ production, tau phosphorylation, and synapse loss in multiple models, and recent work in AD cerebral organoids has highlighted Wnt pathway dysregulation as a core feature of disease progression (Kostes and Brafman, 2023; Tapia-Rojas and Inestrosa, 2018).”

• cites Kostes and Brafman, 2023 sourceSupported
• cites Tapia-Rojas and Inestrosa, 2018 sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

Recent work in AD cerebral organoids has highlighted Wnt pathway dysregulation as a core feature of disease progression.

“Aberrant Wnt signaling has been implicated in Aβ production, tau phosphorylation, and synapse loss in multiple models, and recent work in AD cerebral organoids has highlighted Wnt pathway dysregulation as a core feature of disease progression (Kostes and Brafman, 2023; Tapia-Rojas and Inestrosa, 2018).”

• cites Kostes and Brafman, 2023 sourcePartly supported

  Section 6 (Conclusions; page unavailable) links WNT signaling to Aβ pathology, tau hyperphosphorylation, and synaptic loss. Section 5 (Future Trends; page unavailable) discusses hiPSC-based AD models as a way to investigate unanswered questions, but does not report cerebral-organoid work establishing WNT dysregulation as a core feature of disease progression. (LLM, conf=0.88)

  Experimental — accuracy not yet measured
• cites Tapia-Rojas and Inestrosa, 2018 sourcePartly supported

  The 'Role of Wnt Signaling in the Pathogenesis of AD' section links Wnt signaling loss to accelerated AD pathology, including Aβ production and tau phosphorylation. But it describes mouse models, not AD cerebral organoids, so it does not support the organoid-specific part of the claim. Page numbers were not available in our copy. (LLM, conf=0.87)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

Cadherin signaling has been linked to synaptic adhesion stability and neurodegeneration.

“Cadherin signaling has also been linked to synaptic adhesion stability and neurodegeneration (Ando et al., 2011; Arikkath and Reichardt, 2008; Laszlo and Lele, 2022; Mysore et al., 2008), and APOE isoforms differentially modulate components of cadherin–catenin complexes (Ahmad et al., 2020; Zhang et al., 2024).”

• cites Ando et al., 2011 sourceSupported
• cites Arikkath and Reichardt, 2008 sourceSupported
• cites Laszlo and Lele, 2022 sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

Introducing the R136S mutation into APOE4 backgrounds robustly rescues APOE4-driven tau pathology in mouse models and human iPSC-derived neurons.

“Similarly, Nelson et al. (2023) demonstrated that introducing the R136S mutation into APOE4 backgrounds robustly rescues APOE4-driven tau pathology in mouse models and human iPSC-derived neurons, suggesting a broad tau-protective capacity of APOE3ch/R136S in a late-onset AD risk context.”

• cites Nelson et al., 2023 sourcePartly supported

  The Results (Fig. 1 and “E4-S/S reduces p-Tau accumulation in human neurons”; page numbers unavailable) support rescue of APOE4-driven tau pathology in tauopathy mice and hiPSC-derived neurons with homozygous R136S. The claim omits that qualification: the paper reports no comparable tau-pathology protection from heterozygous R136S. (LLM, conf=0.88)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing).

IL1B is a major mediator of AD-associated neuroinflammatory signaling.

“BDNF is a major regulator of neuronal survival and synaptic plasticity and has been linked to synaptic dysfunction in AD (Gao et al., 2022; Lu et al., 2014), whereas IL1B is a major mediator of AD-associated neuroinflammatory signaling (Lopez-Rodriguez et al., 2021).”

• cites Lopez-Rodriguez et al., 2021 sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

Previous evidence indicates that presenilins influence synaptic function and intracellular calcium homeostasis.

“This broad and mixed response is consistent with the wider perturbation of interleukin, TGF-β, Wnt, glutamatergic, and presenilin signaling observed in our pathway analysis and with previous evidence that presenilins influence synaptic function and intracellular calcium homeostasis (Ho and Shen, 2011; Shen and Kelleher, 2007).”

• cites Ho and Shen, 2011 sourceSupported
• cites Shen and Kelleher, 2007 sourceSupported

Probably not a substantial claim: may not pass S3 (load-bearing).

Predicted HIF1A activation may provide an additional link to APP/Aβ biology because HIF1A has been shown to increase BACE1 expression and γ-secretase activity under hypoxic conditions.

“Notably, predicted HIF1A activation may provide an additional link to APP/Aβ biology because HIF1A has been shown to increase BACE1 expression and γ-secretase activity under hypoxic conditions (Alexander et al., 2022; Guglielmotto et al., 2009b).”

• cites Alexander et al., 2022 sourceSupported
• cites Guglielmotto et al., 2009bNot matched

  Couldn’t be matched to a paper in Crossref, so it can’t be checked.

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

BDNF is a major regulator of neuronal survival and synaptic plasticity and has been linked to synaptic dysfunction in AD.

“BDNF is a major regulator of neuronal survival and synaptic plasticity and has been linked to synaptic dysfunction in AD (Gao et al., 2022; Lu et al., 2014), whereas IL1B is a major mediator of AD-associated neuroinflammatory signaling (Lopez-Rodriguez et al., 2021).”

• cites Gao et al., 2022 sourceSupported
• cites Lu et al., 2014Not matched

  Couldn’t be matched to a paper in Crossref, so it can’t be checked.

Probably not a substantial claim: may not pass S3 (load-bearing).

APOE isoforms differentially modulate components of cadherin-catenin complexes.

“Cadherin signaling has also been linked to synaptic adhesion stability and neurodegeneration (Ando et al., 2011; Arikkath and Reichardt, 2008; Laszlo and Lele, 2022; Mysore et al., 2008), and APOE isoforms differentially modulate components of cadherin–catenin complexes (Ahmad et al., 2020; Zhang et al., 2024).”

• cites Ahmad et al., 2020 sourcePartly supported

  The Results (‘Association of proteins with APOE’; page unavailable) report different plasma levels of CDH6, a cadherin, across APOE genotype groups. The paper does not show that APOE isoforms modulate cadherin–catenin complexes or their components beyond CDH6, and the observed association does not establish modulation. (LLM, conf=0.87)

  Experimental — accuracy not yet measured
• cites Zhang et al., 2024 sourcePartly supported

  The Results section on VE-cadherin reports that mCRP significantly reduced VE-cadherin–CD31 colocalization in ApoE4 mice, but not significantly in the other ApoE groups. This supports an isoform-dependent effect on an endothelial cadherin-associated junction under mCRP exposure; the passages do not establish modulation of catenin components or cadherin–catenin complexes generally. Page numbers were not available in our copy. (LLM, conf=0.86)

  Experimental — accuracy not yet measured

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

PPARGC1A/PGC-1α regulates mitochondrial function and cellular responses to oxidative stress and has been implicated in AD-associated metabolic dysfunction.

“PPARGC1A/PGC-1α regulates mitochondrial function and cellular responses to oxidative stress and has been implicated in AD-associated metabolic dysfunction (Sweeney and Song, 2016).”

• cites Sweeney and Song, 2016 sourceSupported

May combine two claims.

CDK2 and EIF2AK2 were both reduced in APPdp APOE3ch cultures.

“Notably, CDK2 and EIF2AK2 were both reduced in APPdp APOE3ch cultures, paralleling the reduction in pTau231 observed in this genetic background.”

May combine two claims.

In APPdp APOE3ch clones, phosphorylated tau (Thr231) levels were significantly reduced compared to APOE3, with no changes in total tau levels.

“In contrast, the APPdp APOE3ch clones exhibited a significant reduction in phosphorylated tau levels compared to APOE3, with no changes in total tau levels (Figure 3e).”

• Also stated in: § Discussion · hedged

  “In contrast, APPdp cultures carrying the APOE3ch variant exhibited a significant reduction in pTau231 without changes in total tau, suggesting a reduction in this specific tau phosphorylation marker rather than a generalized effect on tau pathology.”

May combine two claims.

The sAPPβ/sAPPα ratio was significantly decreased in the APPdp APOE3ch line, with no notable change in this ratio in the PS1E280A line.

“Furthermore, the sAPPβ/sAPPα ratio was significantly decreased in the APPdp APOE3ch line, with no notable change in this ratio in the PS1E280A line (Figure 4d).”

May combine two claims.

In PS1E280A APOE3ch clones, total tau levels significantly increased, while phosphorylated tau (Thr231) levels remained unchanged.

“In the PS1E280A APOE3ch clones, total tau levels significantly increased, while phosphorylated tau levels remained unchanged (Figure 3d).”

• Also stated in: § Discussion · hedged

  “In PS1E280A neural cultures, the APOE3ch variant did not alter phosphorylated tau at Thr231, although it modestly increased total tau levels, indicating that APOE3ch does not substantially alter pTau231 levels in this genetic context.”

May combine two claims.

In the APPdp cell lines, no significant difference in sAPPα levels was observed, but sAPPβ levels were significantly reduced in the APOE3ch line relative to APOE3.

“Conversely, in the APPdp cell lines, no significant difference in sAPPα levels was observed, but sAPPβ levels were significantly reduced in the APOE3ch line relative to APOE3 (Figures 4b, c).”

May combine two claims.

Two sets of isogenic APOE3 and APOE3ch hiPSC lines were generated and characterized, each containing distinct familial mutations and exhibiting hallmark traits of hiPSCs.

“Overall, we have successfully generated and characterized two sets of isogenic APOE3 and APOE3ch hiPSC lines, each containing distinct familial mutations, and exhibiting all the hallmark traits of hiPSCs.”

May combine two claims.

In the PS1E280A isogenic line, APOE3ch cultures showed a significant increase in sAPPα levels compared to APOE3 neurons, with no change in sAPPβ levels.

“In the PS1E280A isogenic line, APOE3ch cultures showed a significant increase in sAPPα levels compared to APOE3 neurons, with no change in sAPPβ levels (Figures 4b, c).”

May combine two claims.

Analysis of neural cultures revealed a large percentage of cells expressing mature neuronal markers TUJ1, MAP2, and NEUN, and numerous S100β-positive astrocytes.

“Analysis of neural cultures generated from the PS1E280A and APPDP isogenic cell lines revealed a large percentage of cells that expressed the mature neuronal markers TUJ1, MAP2, and NEUN (Figure 2a). In addition, these differentiated cultures also resulted in the generation of numerous S100β-positive astrocytes (Figure 2b).”

May combine two claims.

The three AD-associated regulators identified in APPdp cultures consisted of predicted activation of PPARGC1A and BDNF and inhibition of IL1B.

“In contrast, the three AD-associated regulators identified in APPdp cultures consisted of predicted activation of PPARGC1A and BDNF and inhibition of IL1B.”

May combine two claims.

APOE3ch did not alter neuronal or astrocytic differentiation, the specification of neuronal subtypes, or expression of synaptic gene markers.

“Across both PS1E280A and APPdp backgrounds, APOE3ch did not alter neuronal or astrocytic differentiation, the specification of neuronal subtypes, or expression of synaptic gene markers.”

May combine two claims.

Gene expression analysis revealed a notable increase in ADAM9 expression in PS1E280A APOE3ch cultures, along with elevated BACE2 levels.

“Gene expression analysis revealed a notable increase in ADAM9 expression in PS1E280A APOE3ch cultures, along with elevated BACE2 levels.”

May combine two claims.

2,004 unique DEGs were specific to the PS1E280A isogenic line, while 488 unique DEGs were found in the APPdp isogenic line.

“Additionally, 2,004 unique DEGs were specific to the PS1E280A isogenic line, while 488 unique DEGs were found in the APPdp isogenic line, highlighting mutation-specific transcriptional profiles (Figure 5b).”

May combine two claims.

Additional PS1E280A-associated changes included predicted activation of HIF1A, APP, NFκB-related regulators, CREB1, and NGF together with predicted inhibition of APOE and BACE1.

“Additional PS1E280A-associated changes included predicted activation of HIF1A, APP, NFκB-related regulators, CREB1, and NGF together with predicted inhibition of APOE and BACE1.”

May combine two claims.

In the PS1E280A mutation, APOE3ch significantly affected angiogenesis, inotropic glutamate receptor signaling, interleukin signaling, TGF-beta signaling, gonadotropin-releasing hormone receptor signaling, Wnt signaling, Alzheimer disease-presenilin signaling, and integrin signaling.

“In contrast, in the PS1E280A mutation, APOE3ch significantly affected angiogenesis, inotropic glutamate receptor signaling, interleukin signaling, TGF-beta signaling, gonadotropin-releasing hormone receptor signaling, Wnt signaling, Alzheimer disease-presenilin signaling, and integrin signaling.”

May combine two claims.

IL1B and PPARGC1A were the only AD-associated regulators significantly altered in both genetic backgrounds, but their predicted activities were opposite: IL1B was activated and PPARGC1A inhibited in PS1E280A cultures, whereas IL1B was inhibited and PPARGC1A activated in APPdp cultures.

“Notably, IL1B and PPARGC1A were the only AD-associated regulators significantly altered in both genetic backgrounds, but their predicted activities were opposite as IL1B was activated and PPARGC1A inhibited in PS1E280A cultures, whereas IL1B was inhibited and PPARGC1A activated in APPdp cultures.”

May combine two claims.

In the Cadherin pathway, some genes were consistently affected in the same direction, while others exhibited opposing effects depending on the mutation.

“Further examination of Cadherin pathway-specific genes revealed that while some were consistently affected in the same direction, others exhibited opposing effects depending on the mutation (Figure 5d).”

May combine two claims.

APOE3ch reduces total Aβ40 and Aβ42 production exclusively in the APPdp background, with no corresponding effect observed in PSEN1 E280A cultures.

“To that end, a major advance from our work is the discovery that APOE3ch reduces total Aβ40 and Aβ42 production exclusively in the APPdp background, with no corresponding effect observed in PSEN1 E280A cultures.”

May combine two claims.

APOE3ch increased sAPPα levels in PS1E280A cultures without altering amyloidogenic fragments.

“In contrast, APOE3ch increased sAPPα levels in PS1E280A cultures without altering amyloidogenic fragments.”

May combine two claims.

APOE3ch shifts APP processing away from amyloidogenic pathways in APPdp cultures, specifically decreasing sAPPβ, β-CTF, and sAPPβ/sAPPα ratios.

“Consistent with this, we found that APOE3ch shifts APP processing away from amyloidogenic pathways in APPdp cultures–specifically decreasing sAPPβ, β-CTF, and sAPPβ/sAPPα ratios, a profile indicative of reduced β-secretase–dependent processing.”

May combine two claims.

APOE3ch altered distinct sets of tau-associated kinases in the two ADAD backgrounds, with significant changes in CSNK1D, CDK17, MARK3, and DDR2 in PS1E280A cultures but CDK2 and EIF2AK2 in APPdp cultures.

“APOE3ch altered distinct sets of tau-associated kinases in the two ADAD backgrounds, with significant changes in CSNK1D, CDK17, MARK3, and DDR2 in PS1E280A cultures but CDK2 and EIF2AK2 in APPdp cultures.”

May combine two claims.

In both PS1E280A and APPdp isogenic sets, APOE3ch neural cultures exhibited distinct gene expression signatures relative to APOE3 controls, with upregulated expression of genes linked to Wnt/β-catenin and cadherin pathways.

“In both PS1E280A and APPdp isogenic sets, APOE3ch neural cultures exhibited distinct gene expression signatures relative to APOE3 controls, with upregulated expression of genes linked to Wnt/β-catenin and cadherin pathways.”

• AssumptionRests on an assumption: Upregulation of Wnt and cadherin pathway gene expression indicates increased Wnt and cadherin signaling.

May combine two claims.

PS1E280A cultures exhibited more than twice as many differentially expressed genes as APPdp cultures, together with a broader spectrum of perturbed pathways.

“PS1E280A cultures exhibited more than twice as many differentially expressed genes as APPdp cultures, together with a broader spectrum of perturbed pathways.”

May combine two claims.

The PS1E280A profile included predicted activation of inflammatory and stress-associated regulators such as IL1B, NFκB-related factors, HIF1A, and APP, together with predicted inhibition of APOE, BACE1, and PPARGC1A.

“The PS1E280A profile included predicted activation of inflammatory and stress-associated regulators such as IL1B, NFκB-related factors, HIF1A, and APP, together with predicted inhibition of APOE, BACE1, and PPARGC1A.”

May combine two claims.

APOE3ch reduces amyloidogenic APP processing, Aβ production, and tau phosphorylation in APP duplication backgrounds.

“Using isogenic hiPSC-derived neural models, we demonstrate that APOE3ch reduces amyloidogenic APP processing, Aβ production, and tau phosphorylation in APP duplication backgrounds, while primarily modulating non-amyloidogenic processing and transcriptional programs linked to synaptic signaling in PS1E280A cultures.”

• AssumptionRests on an assumption: The isogenic hiPSC-derived neural cultures model APOE3ch's effects on AD-relevant phenotypes in humans.

May combine two claims.

APOE3ch consistently influences pathways associated with synaptic resilience while differentially modulating amyloid and tau pathology.

“The variant consistently influences pathways associated with synaptic resilience while differentially modulating amyloid and tau pathology.”

May combine two claims.

APOE3ch acts as a context-dependent modifier of Alzheimer's disease pathology, with protective effects varying by genetic background.

“These findings demonstrate that APOE3ch acts as a context-dependent modifier of Alzheimer’s disease pathology, with protective effects varying by genetic background.”

May combine two claims.

APOE3ch modulates overall Aβ production without altering the relative balance of pathogenic Aβ species.

“Despite these changes in Aβ levels, the Aβ42/Aβ40 ratio remained consistent across both the PS1E280A and APPdp isogenic pairs, suggesting that the APOE3ch modulates overall Aβ production without altering the relative balance of pathogenic Aβ species (Figure 3c).”

May combine two claims.

One homozygous APOE3ch clone was confirmed in the APPdp line with no off-target edits detected.

“Genotyping at the APOE112, APOE136, and APOE158 site confirmed one homozygous APOE3ch clones (Figure 1a), with no off-target edits detected (Supplementary Figure 4).”

Probably not a substantial claim: may not pass S3 (load-bearing).

Flow cytometry gating was established using isotype controls.

“Gating was established using isotype controls, and data analysis was performed using FlowJo software.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

Data normality was assessed using the Shapiro-Wilk test, and all datasets satisfied the assumption of normality.

“Data normality was assessed using the Shapiro–Wilk test, and all datasets satisfied the assumption of normality.”

Classified as probably not a substantial claim.

Three clones were selected for further analysis to minimize the possibility that observed phenotypes were a result of clonal variation.

“We selected 3 clones for further analysis to minimize the possibility that observed phenotypes were a result of clonal variation.”

Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

APOE isoforms differentially regulate multiple aspects of Aβ metabolism, including APP trafficking and processing, Aβ production, cellular uptake, and clearance, with APOE4 linked to increased APP endocytosis and Aβ production compared with APOE2 and APOE3.

“Consistent with this broader role, APOE isoforms have been shown to differentially regulate multiple aspects of Aβ metabolism, including APP trafficking and processing, Aβ production, cellular uptake, and clearance, with APOE4 linked to increased APP endocytosis and Aβ production compared with APOE2 and APOE3 (He et al., 2007; Ye et al., 2005).”

• cites He et al., 2007Not matched

  Couldn’t be matched to a paper in Crossref, so it can’t be checked.

• cites Ye et al., 2005Not matched

  Couldn’t be matched to a paper in Crossref, so it can’t be checked.

May combine two claims.

Several clones were homozygous for the APOE3ch mutation with no off-target editing.

“Genotyping at the APOE112, APOE136, and APOE158 site revealed several clones with no off-targeting editing (Supplementary Figure 2) that were homozygous for the APOE3ch mutation (Figure 1a and Supplementary Figure 3a).”

Classified as probably not a substantial claim.

Immunofluorescence images were analyzed using identical image acquisition and processing parameters across all samples, with brightness and contrast maintained consistently for each channel to enable unbiased comparisons.

“Fluorescence images were analyzed using identical image acquisition and processing parameters across all samples. Brightness and contrast settings were maintained consistently for each fluorescence channel to enable unbiased comparisons between experimental groups.”

May combine two claims.

One clone was selected with the desired PS1E280A mutation and no off-target editing.

“One clone was selected with the desired PS1E280A mutation (Figure 1a) and no off-target editing (Supplementary Figure 1).”

May combine two claims.

Each edited clone displayed characteristic hiPSC morphology and expressed markers of the undifferentiated state (OCT4, SOX2, NANOG, TRA-1-81, SSEA4).

“Each clone displayed characteristic hiPSC morphology (Figure 1b and Supplementary Figure 3b), expressed markers of the undifferentiated state (OCT4, SOX2, NANOG, TRA-1-81, SSEA4) (Figures 1c, d and Supplementary Figures 3c, d), and demonstrated trilineage differentiation potential with expression of mesoderm, endoderm, and ectoderm markers (Figure 1e and Supplementary Figure 3e).”

May combine two claims.

APOE3ch produced a broader transcriptional response but comparatively modest effects on extracellular Aβ and APP processing in PS1E280A cultures, whereas APPdp cultures exhibited a more restricted transcriptional response accompanied by reductions in amyloidogenic APP processing, extracellular Aβ, and pTau231.

“Specifically, APOE3ch produced a broader transcriptional response but comparatively modest effects on extracellular Aβ and APP processing in PS1E280A cultures, whereas APPdp cultures exhibited a more restricted transcriptional response accompanied by reductions in amyloidogenic APP processing, extracellular Aβ, and pTau231.”

May combine two claims.

APOE3ch's influence on Cadherin signaling is mutation-dependent, potentially altering interactions with key pathway components and leading to distinct downstream effects.

“This suggests that APOE3ch’s influence on Cadherin signaling is mutation-dependent, potentially altering interactions with key pathway components and leading to distinct downstream effects.”

May combine two claims.

APOE3ch produces both quantitatively broader and qualitatively distinct regulatory responses depending on the underlying ADAD mutation.

“Together, these findings demonstrate that APOE3ch produces both quantitatively broader and qualitatively distinct regulatory responses depending on the underlying ADAD mutation.”

May combine two claims.

The APOE3ch variant modulates APP processing at both transcriptional and post-translational levels in a FAD mutation-dependent manner, potentially contributing to its protective effects in AD.

“Altogether, these findings suggest that the APOE3ch variant modulates APP processing at both transcriptional and post-translational levels in a FAD mutation-dependent manner, potentially contributing to its protective effects in AD.”

May combine two claims.

APOE3ch's role in modulating disease-related pathways is complex and its effects are highly context-dependent.

“Overall, these findings highlight the complexity of APOE3ch’s role in modulating disease-related pathways and suggest that its effects are highly context-dependent.”

May combine two claims.

APOE3ch-mediated protection arises not from altered APOE abundance but from downstream signaling changes or disrupted protein-protein interactions such as reduced HSPG engagement.

“Together, these findings indicate that APOE3ch-mediated protection arises not from altered APOE abundance but from downstream signaling changes or disrupted protein–protein interactions such as reduced HSPG engagement.”

May combine two claims.

The reduction in sAPPβ, β-CTF, and extracellular Aβ observed in APPdp cultures may reflect altered APP trafficking and processing, altered downstream Aβ turnover, or a combination of these mechanisms rather than a simple reduction in Aβ production.

“Accordingly, the reduction in sAPPβ, β-CTF, and extracellular Aβ observed in APPdp cultures may reflect altered APP trafficking and processing, altered downstream Aβ turnover, or a combination of these mechanisms rather than a simple reduction in Aβ production.”

Probably not a substantial claim: may not pass S3 (load-bearing).

Transcript abundance does not directly establish kinase activity, phosphorylation state, or direct kinase-tau interactions.

“However, because transcript abundance does not directly establish kinase activity, phosphorylation state, or direct kinase–tau interactions, these genes should be considered candidate mediators that will require biochemical and functional validation.”

May combine two claims.

APOE3ch-associated changes in pTau231 and total tau are conditional on the underlying genetic background, with reduced pTau231 observed in APPdp cultures but minimal effects on pTau231 in PS1E280A cultures.

“In contrast, our findings indicate that APOE3ch-associated changes in pTau231 and total tau are conditional on the underlying genetic background, with reduced pTau231 observed in APPdp cultures but minimal effects on pTau231 in PS1E280A cultures.”

May combine two claims.

APOE3ch engages a broad signaling response in the PS1E280A background but a more focused metabolic, neurotrophic, and inflammatory regulatory program in APPdp cells.

“Together, these findings suggest that APOE3ch engages a broad signaling response in the PS1E280A background but a more focused metabolic, neurotrophic, and inflammatory regulatory program in APPdp cells, further supporting the conclusion that its protective mechanisms are strongly dependent on the underlying ADAD mutation.”